作者: Eric Kuhrts
DOI:
关键词:
摘要: Disclosed is a pharmaceutical composition including therapeutic quantity of an joint restorative compound selected from aminosugars, chondroitin, collagen 2, or methyl sulfonyl methane; and COX-2 inhibitor having IC50-WHMA COX-2/COX-1 ratio ranging about 0.23 to 3.33. Also disclosed are methods for the treatment, regeneration, repair connective tissue in mammals treating osteoarthritis, rheumatoid arthritis acute pain utilizing